Graphite Bio, Inc.
Graphite Bio, Inc.
Share · US38870X1046 · GRPH (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % -82,81 %

Company Profile for Graphite Bio, Inc. Share

Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression; GPH201 for the treatment of X-linked severe combined immunodeficiency syndrome; and GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Company Data

Name Graphite Bio, Inc.
Company Graphite Bio, Inc.
Symbol GRPH
Website https://www.graphitebio.com
Primary Exchange XNAS NASDAQ
ISIN US38870X1046
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Ms. Kimberlee Cobleigh Drapkin CPA
Market Capitalization 185 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 201 Haskins Way, 94080 South San Francisco
IPO Date 2021-06-25
Dividends from 'Graphite Bio, Inc.'
Ex-Date Dividend per Share
22.03.2024 0,15 USD

Ticker Symbols

Name Symbol
NASDAQ GRPH

More Shares

Investors who Graphite Bio, Inc. hold also have the following shares in their portfolio:
EFSF 15/23 MTN
EFSF 15/23 MTN Bond
PGIM ETF Trust PGIM Total Return Bond ETF
PGIM ETF Trust PGIM Total Return Bond ETF ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025